Andrew J. Rice
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Andrew J. Rice has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
- Douglas A. Mitchell
Vanderbilt University School of Medicine
7 shared publications - Wilfred A. van der Donk
University of Illinois at Urbana-Champaign
2 shared publications - Albert A. Bowers
University of North Carolina at Chapel Hill
1 shared publication - Alexander J. Battiste
Department of Chemistry, University of Illinois at Urbana-Champaign, Urbana, USA
1 shared publication Andi Liu
Department of Microbiology
1 shared publicationAutumn M. Frerk
Department of Chemistry, University of Illinois at Urbana-Champaign, Urbana, USA
1 shared publication
Latest Publications
- Open Access
- 12 March 2026
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 65 (7) , 1056-1069
Backbone Thioamidation of a Ribosomal Subunit Protein in Pseudomonadota
The ribosome is an intensively studied machine responsible for protein synthesis. Recent high-resolution structures of the Escherichia coli ribosome unexpectedly revealed a thioamide on the large subunit protein uL16. This unusual and easily overlooked modification replaces oxygen with sulfur in the peptide backbone, and here, the modification is proximal to the peptidyl transferase center (PTC). The responsible enzyme has remained unidentified, although methanogenic YcaO enzymes are known to catalyze thioamidation of methyl-coenzyme M reductase. Here, we use several approaches to assign EcYcaO as the enzyme responsible for uL16 thioamidation. We began by individually predicting the structures of all E. coli proteins complexed with EcYcaO, revealing that EcuL16 was the only protein forming a high-confidence, catalytically competent interaction. Furthermore, we performed mutational analysis of the EcYcaO-EcuL16 binding interface, revealing an extensive, electrostatically complementary surface atypical of characterized YcaO enzymes. In log-phase E. coli, we observed a complex, nonlinear growth relationship between thioamidation and β-hydroxylation of EcuL16-Arg81, a neighboring PTC modification. Beyond E. coli, bioinformatics surveys predict that several thousand Pseudomonadota organisms will equivalently perform uL16 thioamidation. This prediction was validated for two Gram-negative human pathogens, Klebsiella pneumoniae and Pseudomonas aeruginosa. Overall, this work has elucidated the enzyme responsible for uL16 thioamidation and demonstrated that this unusual modification is widespread in Pseudomonadota. Further, we have laid a critical foundation for understanding both the mechanism by which this modification is formed and its functional consequences. The in silico approach leveraged here could also find broader use in identifying gene-encoded substrates for enzymes.
- 12 March 2026
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 65 (7) , 1056-1069
Open AccessBackbone Thioamidation of a Ribosomal Subunit Protein in Pseudomonadota
The ribosome is an intensively studied machine responsible for protein synthesis. Recent high-resolution structures of the Escherichia coli ribosome unexpectedly revealed a thioamide on the large subunit protein uL16. This unusual and easily overlooked modification replaces oxygen with sulfur in the peptide backbone, and here, the modification is proximal to the peptidyl transferase center (PTC). The responsible enzyme has remained unidentified, although methanogenic YcaO enzymes are known to catalyze thioamidation of methyl-coenzyme M reductase. Here, we use several approaches to assign EcYcaO as the enzyme responsible for uL16 thioamidation. We began by individually predicting the structures of all E. coli proteins complexed with EcYcaO, revealing that EcuL16 was the only protein forming a high-confidence, catalytically competent interaction. Furthermore, we performed mutational analysis of the EcYcaO-EcuL16 binding interface, revealing an extensive, electrostatically complementary surface atypical of characterized YcaO enzymes. In log-phase E. coli, we observed a complex, nonlinear growth relationship between thioamidation and β-hydroxylation of EcuL16-Arg81, a neighboring PTC modification. Beyond E. coli, bioinformatics surveys predict that several thousand Pseudomonadota organisms will equivalently perform uL16 thioamidation. This prediction was validated for two Gram-negative human pathogens, Klebsiella pneumoniae and Pseudomonas aeruginosa. Overall, this work has elucidated the enzyme responsible for uL16 thioamidation and demonstrated that this unusual modification is widespread in Pseudomonadota. Further, we have laid a critical foundation for understanding both the mechanism by which this modification is formed and its functional consequences. The in silico approach leveraged here could also find broader use in identifying gene-encoded substrates for enzymes.
- Open Access
- 17 December 2025
- Published by American Society for Microbiology in mSystems
- Vol. 10 (12) , e0125225
Structure-based discovery and definition of RiPP recognition elements
Ribosomally synthesized and post-translationally modified peptides (RiPPs) are a large class of natural products with wide-ranging structural and functional diversity. Central to many RiPP biosynthetic pathways is the RiPP Recognition Element (RRE), a structurally conserved peptide-binding domain that enables class-independent genome mining. Bioinformatic tools, such as RRE-Finder, have leveraged this domain to identify novel RiPPs, but accuracy has been limited by high false-positive rates. To improve accuracy, we assessed whether structure-based searching of the AlphaFold database with the rapid tertiary structure alignment tool Foldseek could reduce false-positive rates and identify previously unretrievable, sequence-divergent RREs. We used these divergent RREs to build 11 new Foldseek-derived Hidden Markov Models (HMMs) and refined existing models through improved seed alignments, domain excision, bit score thresholds, and Pfam filters. Improved precision mode HMMs retrieved nearly twice as many RREs from the UniProt database as the original models, including novel domain fusions. In total, the updated workflow identified >90,000 high-confidence RREs. To further characterize these RREs and assess their functional relevance, we used a combined bioinformatic and AlphaFold 3 approach to predict over 8,000 RRE–peptide complexes. This enabled the mapping of 13 distinct recognition sequences across known RiPP classes. We further validated the ability of AlphaFold to predict precursor peptide interactions with their cognate RRE domains through binding assays to streamline recognition sequence and putative substrate identification. Together, these improvements enhance the accuracy and scope of RRE-Finder, improving access to previously hidden RRE-dependent biosynthetic pathways. IMPORTANCE: Genome mining relies heavily on sequence similarity searches, which severely limit the discovery potential for sequence-divergent proteins. To mitigate this challenge for RRE domain discovery, we employed structure-based alignments to predict sequence-divergent RREs using Foldseek. The newly identified RRE domains were then used to build new HMMs for use by RRE-Finder. This process identified 5,000 previously unidentified but high-confidence RRE domains. Representatives in this sequence-divergent group retain the canonical RRE fold but display new domain fusions, offering additional bioinformatic handles for genome mining. In parallel, AlphaFold 3 modeling of RRE-precursor peptide interactions enabled the identification of 13 distinct recognition sequence motifs, spanning many RiPP biosynthetic pathways. These approaches have significantly expanded the RRE-dependent RiPP biosynthetic landscape.
- 17 December 2025
- Published by American Society for Microbiology in mSystems
- Vol. 10 (12) , e0125225
Open AccessStructure-based discovery and definition of RiPP recognition elements
Ribosomally synthesized and post-translationally modified peptides (RiPPs) are a large class of natural products with wide-ranging structural and functional diversity. Central to many RiPP biosynthetic pathways is the RiPP Recognition Element (RRE), a structurally conserved peptide-binding domain that enables class-independent genome mining. Bioinformatic tools, such as RRE-Finder, have leveraged this domain to identify novel RiPPs, but accuracy has been limited by high false-positive rates. To improve accuracy, we assessed whether structure-based searching of the AlphaFold database with the rapid tertiary structure alignment tool Foldseek could reduce false-positive rates and identify previously unretrievable, sequence-divergent RREs. We used these divergent RREs to build 11 new Foldseek-derived Hidden Markov Models (HMMs) and refined existing models through improved seed alignments, domain excision, bit score thresholds, and Pfam filters. Improved precision mode HMMs retrieved nearly twice as many RREs from the UniProt database as the original models, including novel domain fusions. In total, the updated workflow identified >90,000 high-confidence RREs. To further characterize these RREs and assess their functional relevance, we used a combined bioinformatic and AlphaFold 3 approach to predict over 8,000 RRE–peptide complexes. This enabled the mapping of 13 distinct recognition sequences across known RiPP classes. We further validated the ability of AlphaFold to predict precursor peptide interactions with their cognate RRE domains through binding assays to streamline recognition sequence and putative substrate identification. Together, these improvements enhance the accuracy and scope of RRE-Finder, improving access to previously hidden RRE-dependent biosynthetic pathways. IMPORTANCE: Genome mining relies heavily on sequence similarity searches, which severely limit the discovery potential for sequence-divergent proteins. To mitigate this challenge for RRE domain discovery, we employed structure-based alignments to predict sequence-divergent RREs using Foldseek. The newly identified RRE domains were then used to build new HMMs for use by RRE-Finder. This process identified 5,000 previously unidentified but high-confidence RRE domains. Representatives in this sequence-divergent group retain the canonical RRE fold but display new domain fusions, offering additional bioinformatic handles for genome mining. In parallel, AlphaFold 3 modeling of RRE-precursor peptide interactions enabled the identification of 13 distinct recognition sequence motifs, spanning many RiPP biosynthetic pathways. These approaches have significantly expanded the RRE-dependent RiPP biosynthetic landscape.
- Top Cited PapersOpen Access
- 19 March 2025
- Published by Royal Society of Chemistry (RSC) in Chemical Society Reviews
- Vol. 54 (9) , 4314-4352
Cell-free synthetic biology for natural product biosynthesis and discovery
Natural products have applications as biopharmaceuticals, agrochemicals, and other high-value chemicals. However, there are challenges in isolating natural products from their native producers (e.g. bacteria, fungi, plants). In many cases, synthetic chemistry or heterologous expression must be used to access these important molecules. The biosynthetic machinery to generate these compounds is found within biosynthetic gene clusters, primarily consisting of the enzymes that biosynthesise a range of natural product classes (including, but not limited to ribosomal and nonribosomal peptides, polyketides, and terpenoids). Cell-free synthetic biology has emerged in recent years as a bottom-up technology applied towards both prototyping pathways and producing molecules. Recently, it has been applied to natural products, both to characterise biosynthetic pathways and produce new metabolites. This review discusses the core biochemistry of cell-free synthetic biology applied to metabolite production and critiques its advantages and disadvantages compared to whole cell and/or chemical production routes. Specifically, we review the advances in cell-free biosynthesis of ribosomal peptides, analyse the rapid prototyping of natural product biosynthetic enzymes and pathways, highlight advances in novel antimicrobial discovery, and discuss the rising use of cell-free technologies in industrial biotechnology and synthetic biology.
- 19 March 2025
- Published by Royal Society of Chemistry (RSC) in Chemical Society Reviews
- Vol. 54 (9) , 4314-4352
Top Cited PapersOpen AccessCell-free synthetic biology for natural product biosynthesis and discovery
Natural products have applications as biopharmaceuticals, agrochemicals, and other high-value chemicals. However, there are challenges in isolating natural products from their native producers (e.g. bacteria, fungi, plants). In many cases, synthetic chemistry or heterologous expression must be used to access these important molecules. The biosynthetic machinery to generate these compounds is found within biosynthetic gene clusters, primarily consisting of the enzymes that biosynthesise a range of natural product classes (including, but not limited to ribosomal and nonribosomal peptides, polyketides, and terpenoids). Cell-free synthetic biology has emerged in recent years as a bottom-up technology applied towards both prototyping pathways and producing molecules. Recently, it has been applied to natural products, both to characterise biosynthetic pathways and produce new metabolites. This review discusses the core biochemistry of cell-free synthetic biology applied to metabolite production and critiques its advantages and disadvantages compared to whole cell and/or chemical production routes. Specifically, we review the advances in cell-free biosynthesis of ribosomal peptides, analyse the rapid prototyping of natural product biosynthetic enzymes and pathways, highlight advances in novel antimicrobial discovery, and discuss the rising use of cell-free technologies in industrial biotechnology and synthetic biology.
- Open Access
Peptidic Tryptophan Halogenation by a Promiscuous Flavin-dependent Enzyme
Amino acids undergo numerous enzymatic modifications. However, the broad applicability of amino acid-modifying enzymes for synthetic purposes is limited by narrow substrate scope and often unknown regulatory or accessory factor requirements. Here, we characterize ChlH, a flavin-dependent halogenase (FDH) from the chlorolassin biosynthetic gene cluster. Unlike characterized peptide-modifying FDHs, which are limited to either specifically modified peptides or the termini of linear peptides, ChlH halogenates internal Trp residues of linear peptides, as well as N- and C-terminal Trp. Scanning mutagenesis of the substrate peptide ChlA revealed Trp was tolerated by ChlH at nearly every position. Molecular dynamics simulations corroborated the importance of a C-terminal motif in ChlA and provided insight into the lack of Trp14 chlorination in native chlorolassin. Furthermore, halogenation of disparate ribosomally synthesized and post-translationally modified peptide (RiPP) precursor peptides, pharmacologically relevant peptides, and an internal Trp of a protein was achieved using wild-type ChlH. A rapid cell-free biosynthetic assay provided insight into ChlH’s preferences. In contrast to characterized FDHs, ChlH halogenates diverse peptide sequences, and we predict this promiscuity may find utility in the modification of additional peptide and protein substrates of biotechnological value. Entry for the Table of Contents: ChlH, a flavin-dependent tryptophan halogenase, is reconstituted in vitro and found to be capable of modifying a wide array of diverse peptidic substrates despite showing selectivity on its native substrate peptide ChlA. This highlights its potential use in the biocatalytic production of chlorinated peptides.
Open AccessPeptidic Tryptophan Halogenation by a Promiscuous Flavin-dependent Enzyme
Amino acids undergo numerous enzymatic modifications. However, the broad applicability of amino acid-modifying enzymes for synthetic purposes is limited by narrow substrate scope and often unknown regulatory or accessory factor requirements. Here, we characterize ChlH, a flavin-dependent halogenase (FDH) from the chlorolassin biosynthetic gene cluster. Unlike characterized peptide-modifying FDHs, which are limited to either specifically modified peptides or the termini of linear peptides, ChlH halogenates internal Trp residues of linear peptides, as well as N- and C-terminal Trp. Scanning mutagenesis of the substrate peptide ChlA revealed Trp was tolerated by ChlH at nearly every position. Molecular dynamics simulations corroborated the importance of a C-terminal motif in ChlA and provided insight into the lack of Trp14 chlorination in native chlorolassin. Furthermore, halogenation of disparate ribosomally synthesized and post-translationally modified peptide (RiPP) precursor peptides, pharmacologically relevant peptides, and an internal Trp of a protein was achieved using wild-type ChlH. A rapid cell-free biosynthetic assay provided insight into ChlH’s preferences. In contrast to characterized FDHs, ChlH halogenates diverse peptide sequences, and we predict this promiscuity may find utility in the modification of additional peptide and protein substrates of biotechnological value. Entry for the Table of Contents: ChlH, a flavin-dependent tryptophan halogenase, is reconstituted in vitro and found to be capable of modifying a wide array of diverse peptidic substrates despite showing selectivity on its native substrate peptide ChlA. This highlights its potential use in the biocatalytic production of chlorinated peptides.
- 9 November 2022
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 144 (46) , 21116-21124
Enzymatic Pyridine Aromatization during Thiopeptide Biosynthesis
Thiazole-containing pyritides (thiopeptides) are ribosomally synthesized and post-translationally modified peptides (RiPPs) that have attracted interest owing to their potent biological activities and structural complexity. The class-defining feature of a thiopeptide is a six-membered, nitrogenous heterocycle formed by an enzymatic [4+2]-cycloaddition. In rare cases, piperidine or dehydropiperidine (DHP) is present; however, the aromatized pyridine is considerably more common. Despite significant effort, the mechanism by which the central pyridine is formed remains poorly understood. Building on our recent observation of the Bycroft-Gowland intermediate (i.e., the direct product of the [4+2]-cycloaddition), we interrogated thiopeptide pyridine synthases using a combination of targeted mutagenesis, kinetic assays, substrate analogs, enzyme-substrate crosslinking, and chemical rescue experiments. Collectively, our data delineate roles for several conserved residues in thiopeptide pyridine synthases. A critical tyrosine facilitates the final aromatization step of pyridine formation. This work provides a foundation for further exploration of the [4+2]-cycloaddition reaction and future customization of pyridine-containing macrocyclic peptides.
- 9 November 2022
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 144 (46) , 21116-21124
Enzymatic Pyridine Aromatization during Thiopeptide Biosynthesis
Thiazole-containing pyritides (thiopeptides) are ribosomally synthesized and post-translationally modified peptides (RiPPs) that have attracted interest owing to their potent biological activities and structural complexity. The class-defining feature of a thiopeptide is a six-membered, nitrogenous heterocycle formed by an enzymatic [4+2]-cycloaddition. In rare cases, piperidine or dehydropiperidine (DHP) is present; however, the aromatized pyridine is considerably more common. Despite significant effort, the mechanism by which the central pyridine is formed remains poorly understood. Building on our recent observation of the Bycroft-Gowland intermediate (i.e., the direct product of the [4+2]-cycloaddition), we interrogated thiopeptide pyridine synthases using a combination of targeted mutagenesis, kinetic assays, substrate analogs, enzyme-substrate crosslinking, and chemical rescue experiments. Collectively, our data delineate roles for several conserved residues in thiopeptide pyridine synthases. A critical tyrosine facilitates the final aromatization step of pyridine formation. This work provides a foundation for further exploration of the [4+2]-cycloaddition reaction and future customization of pyridine-containing macrocyclic peptides.
- Open Access
- 17 October 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-15
A scalable platform to discover antimicrobials of ribosomal origin
Ribosomally synthesized and post-translationally modified peptides (RiPPs) are a promising source of new antimicrobials in the face of rising antibiotic resistance. Here, we report a scalable platform that combines high-throughput bioinformatics with automated biosynthetic gene cluster refactoring for rapid evaluation of uncharacterized gene clusters. As a proof of concept, 96 RiPP gene clusters that originate from diverse bacterial phyla involving 383 biosynthetic genes are refactored in a high-throughput manner using a biological foundry with a success rate of 86%. Heterologous expression of all successfully refactored gene clusters inEscherichia colienables the discovery of 30 compounds covering six RiPP classes: lanthipeptides, lasso peptides, graspetides, glycocins, linear azol(in)e-containing peptides, and thioamitides. A subset of the discovered lanthipeptides exhibit antibiotic activity, with one class II lanthipeptide showing low µM activity againstKlebsiella pneumoniae, an ESKAPE pathogen. Overall, this work provides a robust platform for rapidly discovering RiPPs.
- 17 October 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-15
Open AccessA scalable platform to discover antimicrobials of ribosomal origin
Ribosomally synthesized and post-translationally modified peptides (RiPPs) are a promising source of new antimicrobials in the face of rising antibiotic resistance. Here, we report a scalable platform that combines high-throughput bioinformatics with automated biosynthetic gene cluster refactoring for rapid evaluation of uncharacterized gene clusters. As a proof of concept, 96 RiPP gene clusters that originate from diverse bacterial phyla involving 383 biosynthetic genes are refactored in a high-throughput manner using a biological foundry with a success rate of 86%. Heterologous expression of all successfully refactored gene clusters inEscherichia colienables the discovery of 30 compounds covering six RiPP classes: lanthipeptides, lasso peptides, graspetides, glycocins, linear azol(in)e-containing peptides, and thioamitides. A subset of the discovered lanthipeptides exhibit antibiotic activity, with one class II lanthipeptide showing low µM activity againstKlebsiella pneumoniae, an ESKAPE pathogen. Overall, this work provides a robust platform for rapidly discovering RiPPs.
- Open Access
- 17 June 2022
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 144 (25) , 11263-11269
Accessing Diverse Pyridine-Based Macrocyclic Peptides by a Two-Site Recognition Pathway
Macrocyclic peptides are sought-after molecular scaffolds for drug discovery, and new methods to access diverse libraries are of increasing interest. Here, we report the enzymatic synthesis of pyridine-based macrocyclic peptides (pyritides) from linear precursor peptides. Pyritides are a recently described class of ribosomally synthesized and post-translationally modified peptides (RiPPs) and are related to the long-known thiopeptide natural products. RiPP precursors typically contain an N-terminal leader region that is physically engaged by the biosynthetic proteins that catalyze modification of the C-terminal core region of the precursor peptide. We demonstrate that pyritide-forming enzymes recognize both the leader region and a C-terminal tripeptide motif, with each contributing to site-selective substrate modification. Substitutions in the core region were well-tolerated and facilitated the generation of a wide range of pyritide analogues, with variations in macrocycle sequence and size. A combination of the pyritide biosynthetic pathway with azole-forming enzymes was utilized to generate a thiazole-containing pyritide (historically known as a thiopeptide) with no similarity in sequence and macrocycle size to the naturally encoded pyritides. The broad substrate scope of the pyritide biosynthetic enzymes serves as a future platform for macrocyclic peptide lead discovery and optimization.
- 17 June 2022
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 144 (25) , 11263-11269
Open AccessAccessing Diverse Pyridine-Based Macrocyclic Peptides by a Two-Site Recognition Pathway
Macrocyclic peptides are sought-after molecular scaffolds for drug discovery, and new methods to access diverse libraries are of increasing interest. Here, we report the enzymatic synthesis of pyridine-based macrocyclic peptides (pyritides) from linear precursor peptides. Pyritides are a recently described class of ribosomally synthesized and post-translationally modified peptides (RiPPs) and are related to the long-known thiopeptide natural products. RiPP precursors typically contain an N-terminal leader region that is physically engaged by the biosynthetic proteins that catalyze modification of the C-terminal core region of the precursor peptide. We demonstrate that pyritide-forming enzymes recognize both the leader region and a C-terminal tripeptide motif, with each contributing to site-selective substrate modification. Substitutions in the core region were well-tolerated and facilitated the generation of a wide range of pyritide analogues, with variations in macrocycle sequence and size. A combination of the pyritide biosynthetic pathway with azole-forming enzymes was utilized to generate a thiazole-containing pyritide (historically known as a thiopeptide) with no similarity in sequence and macrocycle size to the naturally encoded pyritides. The broad substrate scope of the pyritide biosynthetic enzymes serves as a future platform for macrocyclic peptide lead discovery and optimization.
- 1 June 2019
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 29 (12) , 1487-1491
Microwave-assisted synthesis and in vitro stability of N-benzylamide non-steroidal anti-inflammatory drug conjugates for CNS delivery
- 1 June 2019
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 29 (12) , 1487-1491
Microwave-assisted synthesis and in vitro stability of N-benzylamide non-steroidal anti-inflammatory drug conjugates for CNS delivery